Clinical Trial to Evaluate AB011 Injection in Patients With CLDN18.2-positive Advanced Solid Tumors
Conditions: Solid Tumor; Gastric Cancer; Pancreatic Adenocarcinoma Intervention: Drug: AB011 Injection Sponsors: Carsgen Therapeutics, Ltd.; Shanghai East Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Adenocarcinoma | Cancer | Cancer & Oncology | Clinical Trials | Gastroenterology | Hospitals | Research